Search

1 to 10 of 299
Sort by

Library Entry
Outcomes and biomarker analyses among patients with COVID-19 treated with interleukin 6 (IL-6) receptor antagonist sarilumab at a single institution in Italy

The inflammatory pathology observed in severe COVID-19 disease caused by the 2019 novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is characterized by elevated serum levels of C reactive protein (CRP) and cytokines, including interferon gamma, interleukin 8 (IL-8), and...


Library Entry
Chronic immune checkpoint inhibitor pneumonitis

Pneumonitis from immune checkpoint inhibitors (ICI) is a potentially fatal immune-related adverse event (irAE) from antiprogrammed death 1/programmed death ligand 1 immunotherapy. Most cases of ICI pneumonitis improve or resolve with 4–6 weeks of corticosteroid therapy. Herein, the authors...


Library Entry
Immune-related (IR)-pneumonitis during the COVID-19 pandemic: multidisciplinary recommendations for diagnosis and management

Immune-related (IR)-pneumonitis is a rare and potentially fatal toxicity of anti-PD(L)1 immunotherapy. Expert guidelines for the diagnosis and management of IR-pneumonitis include multidisciplinary input from medical oncology, pulmonary medicine, infectious disease, and radiology specialists....







Web Page
Seattle

Saturday, Oct. 31, 2020 Organizers: Shailender Bhatia, MD – University of Washington Petros Grivas, MD, PhD – University of Washington Andrea M. Perdue, PA – Seattle Cancer Care Alliance ACI-Seattle Live Virtual Program Registration Advanced online registration is NOW AVAILABLE ....


Event
35th Anniversary Annual Meeting & Pre-Conference Programs (SITC 2020)

The Society for Immunotherapy of Cancer’s (SITC) 35 th Anniversary Annual Meeting & Pre-Conference Programs (SITC 2020) will be reimagined as a fully VIRTUAL experience this year to ensure the health and safety of program attendees and their patients, and in celebration of the society’s...

 11-09-2020 08:00 - 11-14-2020 12:00 ET